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The recognition that at least some cancers harbor populations of tumor initiating cells that share traits with normal stem cells
offers insight into targeting therapeutic strategies for their eradication. Three papers in this issue broach this subject from
different angles. In the case of prostate cancer, Witte and colleagues investigate the role played by Bmi-1, a known oncogene
associated with prostate tumors. The authors reveal that normal p63+ stem cells from this tissue depend on the expression of
Bmi-1 for self-renewal and that the loss of this transcriptional repressor protects prostate cells from growth factor-induced
hyperplasia and attenuates Pten-deletion-mediated prostate carcinoma formation. One challenge in identifying candidate
regulatory pathways to target in tumor cells is that they are often shared with normal, essential stem cell function. Akashi
and colleagues, however, have found a surface molecule, TIM-3, that appears to be specifically expressed on human
leukemic stem cells. Furthermore, treatment of xenograft recipients with a modified monoclonal antibody against this protein
both blocked tumor engraftment and diminished established tumor burden without impacting reconstitution with normal
human HSCs. Finally, Ma and coauthors describe a hybrid approach in which
they looked both at surface marker expression and intracellular regulation of
hepatocellular carcinoma (HCC) tumor-forming cells at the level of microRNA.
They find that a CD133+ subpopulation exhibits tumor forming potential both
in vivo and in vitro and that their presence in patient samples correlates with
poor prognosis. Mechanistically, the authors demonstrate that miR-130b regu-
lates growth and self-renewal of CD133+ liver tumor initiating cells by targeting
TP53INP1.Surface Searching
Moving to another tissue, Go¨tz and colleagues demonstrate that CD133, also
known as Prominin-1, when combined with GFAP, marks a population of adult
NSCs that can be isolated at a high purity from the subependymal zone. Tran-
scriptome analysis of this population offers a useful resource for investigating
properties of adult NSCs, and the dual selection strategy that this group developed could be adapted for a range of assays
in other contexts. The importance of defining surface markers that offer reliable identification of tissue stem cells, particularly
in solid organs, is the focus of this issue’s Review article from Barker and Clevers. The authors outline the current state of
knowledge for the intestine, stomach, and skin and highlight how these efforts also offer insight into tumor progression
and potential treatment in these tissues. Amajor aspect of identifying stem cell populations in solid tissues is also to determine
the impact and function of neighboring cells that comprise a portion of the stem
cell niche. Frisen and colleagues demonstrate an interactive plasticity that
connects the two niche cell types in the neurogenic lateral ventricle wall of
the mouse brain. Their analysis reveals that in the context of injury, and in
response to Ephrin and Notch signals, astrocytes give rise to ependymal cells
and ependymal cells give rise to niche astrocytes.Programming and Reprogramming
The past several years have been prolific in terms of producing increasingly
fine-tuned methods for generating pluripotent cells from somatic populations.
Ding and colleagues now demonstrate that in combination with chemical inhib-
itors, human kerotinocytes can be converted to chimera-competent iPSCs with
a single factor, Oct4. In addition, their data suggest that the AKT pathway, via
chemical activation of PDK1, may promote reprogramming by facilitating themetabolic conversion frommitochondrial oxida-
tion to glycolysis, which is more typical of pluripotent cells. In addition to recent efforts to assay whether hiPSCs recapitulate
the pluripotent traits exhibited by hESCs (see Loh and Lim, 7:2 for discussion), Kosik and colleagues now show that two
subsets of pluripotent cells can be defined based on their miRNA signatures. Their results provide a mirMap that separates
populations of human pluripotent populations according to the relative activity of p53 pathway members, rather than distin-
guishing between hESCs and iPSCs, which are each found in both subsets. This classification method might prove useful in
assaying the degree to which candidate iPSC lines have been reprogrammed and, as discussed by Chang and colleagues in
their Preview, highlights that studies of cell surfacemarker or even gene expressionmay not be sufficient to bestow the desig-
nation ‘‘pluripotent.’’ MirMaps may also prove useful to monitor the differentiation process, as the field continues to pursue
methods to generate lineages of interest from pluripotent populations. To that end, Slukvin and colleagues have developed
an hESC differentiation protocol that gives rise to amultipotential mesodermal precursor. The resulting population, which they
dub ‘‘mesenchymoangioblasts,’’ are angiogenic but also produce MSCs that display chondro-, osteo-, and adipogenenic
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